## 



|||||Page|
|---|---|---|---|---|
|Reference and administration<br>details|||||
|Chairman's|statement||||
|Trustee's<br>report (including<br>director's||report)|||
|Independent|auditor's<br>report|||12|
|Consolidated|statement<br>offinancial|activities|||
|Consolidated|and Charity statement|offinancial|position|16|
|Consolidated|statement<br>ofcash flows|||17|
|Notes to the|consolidated<br>statement|ofcash flows||18|
|Notes to the|financial statements|||19|





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 



## 

## 

## 



## 

## 

||||||Unrestricted|Restricted|2021|2020|
|---|---|---|---|---|---|---|---|---|
||||||funds|funds|Total|Total|
||||||||funds|funds|
|||||Note|||6|F|
|INCOME|||||||||
|Voluntaryincome:|||||||||
|Donations<br>& legacies|||||207,415||207,415|296,209|
|Activities forgenerating||funds:|||||||
|Charitable<br>activities|||||52,163|282,355|334,518|710,104|
|Other trading<br>activities|||||871,319||871,319|1,023,060|
|Investment<br>income|||||29,994||29,994|26,073|
|TOTAL INCOME|||||1,160,891|282,355|1,443,246|2,055,446|
|EXPENDITURE|||||||||
|Raising funds:|||||||||
|Fundraising<br>cost of|grants|8,|donations||71,148||71,148|75,892|
|Fundraising<br>activities|||||69,045||69,045|80,405|
|Trading<br>activities|||||457,695||457,695|481,193|
||||||597,888||597,888|637,490|
|Charitable<br>activities:|||||||||
|Advocacy services|8 member||events||45,533|425,003|470,536|488,171|
|Awareness<br>raising|||||160,353||160,353|124,486|
|Trading<br>activities —Patients||support|||256,206||256,206|167,301|
||||||462,092|425,003|887,095|779,958|
|Other costs||||9|96,268||96,268|95,694|
|TOTAL EXPENDITURE|||||1,156,248|425,003|1,581,251|1,513,142|
|NET INCOME/(EXPENDITURE)|||||4,643|(142,648)|(138,005)|542,304|
|RECONCILIATION|OF FUNDS||||||||
|Total funds<br>brought|forward||||2,638,967|318,050|2,957,017|2,414,713|
|TOTAL FUNDS CARRIED||FORWARD|||2,643,610|175,402|2,819,012|2,957,017|





## 

## 

|31 December 2|02|1||||||
|---|---|---|---|---|---|---|---|
|||||2021|2021|2020|2020|
||||Note|Groupf|Charityf|Groupf|Charityf|
|FIXEDASSETS||||||||
|Tangible assets|||17|1,061,737|1,060,465|1,089,612|1,089,040|
|Investments|||18|315,348|315,350|310,897|310,899|
|||||1,377,085|1,375,815|1,400,509|1,399,939|
|CURRENT ASSETS||||||||
|Debtors|||19|315,097|354,679|307,159|610,215|
|Cash at bank and|in|hand|20|1,701,427|1,160,157|2,027,320|1,007,555|
|||||2,016,524|1,514,836|2,334,479|1,617,770|
|CREDITORS||||||||
|Amounts<br>falling due within one<br>year||||574,597|71,639|777,971|60,692|
|NET CURRENT ASSETS||||1,441,927|1,443,197|1,556,508|1,557,078|
|NET ASSETS||||2,819,012|2,819,012|2,957,017|2,957,017|
|FUNDS|||23|||||
|Unrestricted<br>Funds:||||||||
|General charitable||funds||750,000|750,000|750,000|750,000|
|Property<br>funds||||1,055,811|1,055,811|1,084,520|1,084,520|
|Designated<br>funds||||837,799|837,799|804,447|804,447|
|||||2,643,610|2,643,610|2,638,967|2,638,967|
|Restricted<br>Funds||||175,402|175,402|318,050|318,050|
|TOTAL FUNDS||||2,819,012|2,819,012|2,957,017|2,957,017|





## 

|||||2021|2020|
|---|---|---|---|---|---|
||||Notes|6||
|Cash flows from operating|activities:|||||
|Cash generated<br>from operations||||(315,733)|1,185,958|
|Interest paid|||||(5,401)|
|Net cash provided<br>by (used in) operating<br>activities||||(315,733)|1,180,557|
|Cash flows from investing|activities:|||||
|Purchase oftangible<br>fixed assets||||(5,709)||
|Investment<br>in bonds||||(4,451)|(4,797)|
|Net cash provided<br>by (used in) investing<br>activities||||(10,150)|(4,797)|
|Change<br>in cash and cash <br>the reporting<br>period|equivalents|in||(325,893)|1,175,760|
|Cash and cash equivalents<br>beginning<br>ofthe reporting|at the<br>period|||2,027,320|851,560|
|Cash and cash equivalents<br>the reporting<br>period|at the end|of||1,701,427|2,027,320|





## 

## 

|||||2021|2020|
|---|---|---|---|---|---|
|||||K|E|
||Net income for the reporting<br>period (as per the<br>statement<br>offinancial activities)|||(138,005)|542,304|
||Adjustments<br>for:|||||
||Interest paid||||5,401|
||Depreciation|||33,584|33,385|
||Loss on disposal of|fixed assets|||520|
||Decrease/(increase)|in debtors||(7,938)|359,063|
||Increase/(decrease)|in creditors||(203,374)|245,285|
||Net cash provided<br>activities|by (used in) operating||(315,733)|1,185,958|
|2|ANALYSIS OF CHANGES<br>IN NET FUNDS|||||
|||||2021|2020|
|||||E||
||Cash<br>in hand|||1,791|2,289|
||Bank accounts|||1,699,636|2,025,031|
||Total cash and cash equivalents|||1,701,427|2,027,320|





## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

|||||2021|2021|2021|2020|2020|2020|
|---|---|---|---|---|---|---|---|---|---|
||||Unrestricted||Restricted|Total|Unrestricted|Restricted|Total|
|||||fund<br>f|fund<br>f|funds|fund|fundf|fundsf|
|Donations||||189,116||189,116|146,265|40,567|186,832|
|Legacies||||18,299||18,299||109,377|109,377|
|||||207,415||207,415|146,265|149,944|296,209|
|INCOME FROM||||CHARITABLE|ACTIVITIES|||||
||||||2021||2021|2021|2020|
||||||Unrestricted|Restricted||Total|Total|
||||||fund||fund|funds|funds|
||||||F|||f|f|
|Advocacy support||grants|||52,163|238,830||290,993|655,004|
|Conferences|and|Expert||meetings|||6,025|6,025|33,500|
|Physiological|support|||||32,500||32,500||
|MPS awareness|||||||5,000|5,000||
|Family support special|||events||||||11,600|
|Other income|||||||||10,000|
||||||52,163|282,355||334,518|710,104|



## 

||||2020|2020|2020|
|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|
||||fund|fund|funds|
|Advocacy support grants|||93,194|561,810|655,004|
|Conferences|and Expert meetings|||33,500|33,500|
|Family support||special events|11,600||11,600|
|Other income|||10,000||10,000|
||||114,794|595,310|710,104|
|5.<br>OTHER||TRADING ACTIVITIES||||
|||||2021f|2020<br>f|
|Survey income||in subsidiary||240,394|288,928|
|Management|fees in subsidiary|||630,428|733,316|
|Miscellaneous||trading||497|816|
|||||871,319|1,023,060|



## 



## 

## 

||||||||||2021|2020|
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||F|6|
|Rent receivable|||||||||25,424|20,672|
|Interest receivable|||||||||4,570|5,401|
||||||||||29,994|26,073|
|All investment||income|is recorded||in the unrestricted||fund.||||
|7.<br>EXPENDITURE ON||||RAISING FUNDS|||||||
|||||Fundraising||||Commercial|||
|||||Grants &||Fundraising||Trading|Total|Total|
||||Note|Donations|||Events|Activity|2021|2020|
||||||E||E|6|6||
|Staff costs|||15||20,356||37,269|384,310|441,935|459,426|
|Direct costs|||10||33,480||14,464|43,482|91,426|107,853|
|Depreciation|||17||3,273||3,273|1,208|7,754|7,564|
|Support costs|||11||14,039||14,039|28,695|56,773|62,647|
||||||71,148||69,045|457,695|597,888|637,490|
|Attributable|to:||||||||||
|Unrestricted||funds|||71,148||69,045|457,695|597,888|637,490|
|Restricted|funds||||||||||
||||||71,148||69,045|457,695|597,888|637,490|
|EXPENDITURE ON||||RAISING FUNDS —2020|||COMPARATIVES||||
||||||Fundraising|||Commercial|||
||||||Grants &||Fundraising||Trading|Total|
||||Note||Donations|||Events|Activity|2020|
|||||||||E|E|f|
|Staff costs||||15|24,080|||44,977|390,369|459,426|
|Direct costs||||10|32,475|||16,092|59,286|107,853|
|Depreciation||||17|3,227|||3,226|1,111|7,564|
|Support costs||||11|16,110|||16,110|30,427|62,647|
||||||75,892|||80,405|481,193|637,490|
|Attributable|to:||||||||||
|Unrestricted||funds|||75,892|||80,405|481,193|637,490|
|Restricted|funds||||||||||
||||||75,892|||80,405|481,193|637,490|





## 

## 

||||Advocacy|||Commercial|Commercial|||
|---|---|---|---|---|---|---|---|---|---|
||||&Members|Awareness|Trading||Activity|Total|Total|
|||Note|Events|Raising<br>8|Patient||Support<br>F|2021|2020|
|Staff costs<br>Direct costs||15<br>10|355,318<br>28,654|97,527<br>36,857|||256,206|709,051<br>65,511|546,753<br>98,116|
|Research grants<br>Depreciation||12<br>17|16,368|4,910||||21,278|9,400<br>20,980|
|Support costs||11|70,196|21,059||||91,255|104,709|
||||470,536|160,353|||256,206|887,095|779,958|
|Attributable|to:|||||||||
|Unrestricted|funds||45,533|160,353|||256,206|462,092|304,084|
|Restricted|funds||425,003|||||425,003|475,874|
||||470,536|160,353|||256,206|887,095|779,958|
|EXPENDITURE ON|||CHARITABLE|ACTIVITIES —2020||COMPARATIVES||||



|||||Advocacy||Commercial|Commercial||
|---|---|---|---|---|---|---|---|---|
|||||&Members|Awareness|Trading|Activity|Total|
||||Note|Events<br>f|Raising<br>F|Patient|Support|2020<br>f|
|Staff costs|||15|296,353|83,099||167,301|546,753|
|Direct costs|||10|85,733|12,383|||98,116|
|Research grants|||12|9,400||||9,400|
|Depreciation|||17|16,139|4,841|||20,980|
|Support costs|||11|80,546|24,163|||104,709|
|||||488,171|124,486||167,301|779,958|
|Attributable|to:||||||||
|Unrestricted||funds||12,297|124,486||167,301|304,084|
|Restricted||funds||475,874||||475,874|
|||||488,171|124,486||167,301|779,958|





## 

## 

## 

|||||Management||Management||
|---|---|---|---|---|---|---|---|
|||||&Governance|Total|&Governance|Total|
||||Note|2021|2021|2020|2020|
|||||E||E||
|Staff costs|||15|49,504|49,504|49,816|49,816|
|Direct costs|||10|20,794|20,794|16,873|16,873|
|Depreciation|||17|4,552|4,552|4,841|4,841|
|Support costs|||11|21,418|21,418|24,164|24,164|
|||||96,268|96,268|95,694|95,694|
|Attributable|to:|||||||
|Unrestricted||funds||96,268|96,268|95,694|95,694|
|Restricted||funds||||||
|||||96,268|96,268|95,694|95,694|



|10.<br>ALLOCATION<br>O|F|DIRECT|COSTS|||
|---|---|---|---|---|---|
|||||Total|Total|
||||Note|Funds|Funds|
|||||2021|2020|
|Advocacy travel|||||3,210|
|Conference<br>and expert|meetings|||1,876|6,196|
|Support<br>& support events||||14,586|59,456|
|Communications||||40,047|12,383|
|MPS awareness||||8,459||
|Fundraising<br>expenses||||14,464|16,092|
|Donations<br>and tributes|in|memory||224|3,208|
|Management<br>&Governance||||20,794|16,873|
|Survey costs||||43,482|59,286|
|LSD collaborative|||||833|
|Grant consultancy<br>costs||||33,480|32,475|
|Patient welfare gifts||||319|12,830|
|||||177,731|222,842|
|Attributable<br>to raising funds|||7|91,426|107,853|
|Attributable<br>to charitable||activities|8|65,511|98,116|
|Attributable<br>to other costs|||9|20,794|16,873|
|||||177,731|222,842|





## 

## 

## 

|the Year Ended 31December 2021|the Year Ended 31December 2021|the Year Ended 31December 2021|the Year Ended 31December 2021|the Year Ended 31December 2021|the Year Ended 31December 2021|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|11.<br>ALLOCATION<br>OF SUPPORT COSTS||||||||||||||||
||||||Note|||||||2021|||2020|
||||||||||||||||E|
|Recruitment<br>&training costs||||||||||||18,139||10,566||
|General office expenses||||||||||||58,652||91,647||
|Insurance||||||||||||19,936||11,180||
|Subscriptions||||||||||||437|||432|
|Staff welfare||||||||||||8,788||10,081||
|Computer<br>expenses<br>and|software|||||||||||24,784||32,469||
|Professional<br>fees||||||||||||12,350|||7,812|
|Bank charges||||||||||||7,432|||5,887|
|Bad debts|||||||||||||||42|
|Travel and subsistence||||||||||||2,411|||485|
|Consultancy<br>expenses||||||||||||9,317||13,499||
|Auditors<br>remuneration||||||||||||7,200|||6,900|
|Loss on disposal ofasset|||||||||||||||520|
|||||||||||||169,446||191,520||
|Attributable<br>to raising funds||||||||||||56,773||62,647||
|Attributable<br>to charitable|actiwties|||||||||||91,255||104,709||
|Attributable<br>to other costs||||||||||||21,418||24,164||
|||||||||||||169,446||191,520||
|12.<br>GRANTS PAYABLE||||||||||||||||
|||||||||||||2021|||2020|
|||||||||||||6||||
|Grants and donations|||||||||||||||9,400|
|Grants payable to institutions||||||||||||||||
|||||||||||||2021|||2020|
|||||||||||||f|||6|
|Salford Royal NHS Foundation|||Trust||||||||||||9,400|
|In 2020, grants<br>were awarded|||for research|||into the||use of a digital||microfluidics||plafform|for|the rapid||
|assessment<br>of lysosomal||enzyme||activity|and|research||into how hydrotherapy|||can|help alleviate||pain|and|
|improve<br>mobility<br>in patients|||with|MPS|conditions.||Grants||payable|costs|have|all been|attributed||to|
|charitable<br>activity expenditure.||||||||||||||||
|13.<br>NET INCOME/(EXPENDITURE)||||||||||||||||
|Net income/(expenditure)||is stated||after charging/(crediting):||||||||||||
|||||||||||||2021|||2020|
||||||||||||||||6|
|Auditors'<br>remuneration||||||||||||6,000|||6,900|
|Auditors'<br>remuneration|—non audit|||services||||||||1,200||||
|Depreciation||||||||||||33,584||33,385||



## 



## 

## 


|2021 t<br>5.|hese totalled F1,560 (2020:F<br>STAFF COSTS|2,044) for all trustees.||||
|---|---|---|---|---|---|
|||Group||Charity||
|||2021|2020|2021|2020|
|||E|E||E|
|Wages|and salaries|1,051,363|924,436|493,156|439,017|
|Social|security costs|101,771|88,881|44,105|38,114|
|Other|pension costs|47,356|42,677|22,713|21,193|
|||1,200,490|1,055,994|559,974|498,324|



|||||||Group|Group||||
|---|---|---|---|---|---|---|---|---|---|---|
|||||||2021||2020|||
|Chief executives||||||2||2|1|1|
|Administration||||||4||3|4|3|
|Advice,|information||& support|||12||14|12|14|
|Commercial||trading|operation|||15||11|||
|||||||33||30|17|18|
|The number||of higher paid employees||(excluding|employer|pension|costs)|was as|follows:||
||||||Group||||Charity||
||||||2021||2020||2021|2020|
||||||E||E||E|E|





## 

|16.<br>2020 COMPARATIVES|16.<br>2020 COMPARATIVES|16.<br>2020 COMPARATIVES|FOR THE|STATEMENT OF FINANCIAL|STATEMENT OF FINANCIAL|ACTIVITIES||
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|2020|2019|
|||||funds|funds|Total<br>funds|Total<br>funds|
||||Note|6|6|6|6|
|INCOME||||||||
|Voluntaryincome:||||||||
|Donations<br>&legacies|||3|146,265|149,944|296,209|180,732|
|Activities forgenerating||funds:||||||
|Charitable<br>activities|||4|114,794|595,310|710,104|512,817|
|Other trading<br>activities||||1,023,060||1,023,060|981,856|
|Investment<br>income|||6|26,073||26,073|23,362|
|TOTAL INCOME||||1,310,192|745,254|2,055,446|1,698,767|
|EXPENDITURE||||||||
|Raising funds:||||||||
|Fundraising<br>grants|& donations|||63,563||63,563|63,563|
|Fundraising<br>activities||||74,782||74,782|74,782|
|Trading<br>activities||||542,882||542,882|542,882|
|||||681,227||681,227|681,227|
|Charitable<br>activities:||||||||
|Advocacy services|& member events|||12,297|475,874|488,171|720,761|
|Awareness<br>raising||||124,486||124,486|78,517|
|Trading<br>activities||||167,301||167,301||
|||||304,084|475,874|779,958|799,278|
|Other costs||||95,694||95,694|100,639|
|TOTAL EXPENDITURE||||1,037,268|475,874|1,513,142|1,581,144|
|NET INCOME I(EXPENDITURE)||||272,924|269,380|542,304|117,623|
|RECONCILIATION|OF FUNDS|||||||
|Total funds<br>brought|forward|||2,366,043|48,670|2,414,713|2,229,090|
|TOTAL FUNDS CARRIED FORWARD||||2,638,967|318,050|2,957,017|2,414,713|





## 

## 

|7.<br>TANGIBLE FIXEDASSETS||||
|---|---|---|---|
|Group|Freehold|||
||Land and|Plant and||
||buildings|Equipment|Totals|
|||E|F|
|COST||||
|At 1 January 2021|1,435,389|57,767|1,493,156|
|Additions||5,709|5,709|
|Disposals||||
|At 31 December 2021|1,435,389|63,476|1,498,865|
|DEPRECIATION||||
|At 1 January 2021|350,869|52,675|403,544|
|Charge for year|28,708|4,876|33,584|
|Eliminated<br>on disposal||||
|At 31 December 2021|379,577|57,551|437,128|
|NET BOOK VALUE||||
|At 31 December 2021|1,055,812|5,925|1,061,737|
|At 31 December 2020|1,084,520|5,092|1,089,612|
|Charity|Freehold|||
||Land and|Plant and||
||buildings|Equipment|Totals|
||E|f|8|
|COST||||
|At 1 January 2021|1,435,389|49,061|1,484,450|
|Additions||3,801|3,801|
|Disposals||||
|At 31 December 2021|1,435,389|52,862|1,488,251|
|DEPRECIATION||||
|At 1 January 2021|350,869|44,541|395,410|
|Charge for year|28,708|3,668|32,376|
|Eliminated<br>on disposal||||
|At 31 December 2021|379,577|48,209|427,786|
|NET BOOK VALUE||||
|At 31 December 2021|1,055,812|4,653|1,060,465|
|At 31 December 2020|1,084,520|4,520|1,089,040|





## 

## 

|he Year Ended 31 December 20|he Year Ended 31 December 20|he Year Ended 31 December 20|he Year Ended 31 December 20|21||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|18.<br>FIXEDASSET INVESTMENTS||||||||||||||||
||||||||||2021|2021|||2020||2020|
||||||||||Group<br>F|Charity<br>F|||Groupf||Charityf|
|Shares<br>in subsidiary|||||||||||2||||2|
|Donated jewellery|||||||||6,100|6,100|||6,100||6,100|
|Investments<br>in bank bonds|||||||||309,248|309,248||304,797|||304,797|
||||||||||315,348|315,350||310,897|||310,899|
|Investment<br>in subsidiaries||||||||||||||||
|||||Company|||Percentage|||Class of|||No of||Total|
|Subsidiary||||||No.|shareholding|||shares||shares|||value|
|MPS Commercial<br>Limited|||||08621283||||100|Ordinary|F1|||||
|Rare Disease Research Partners<br>Limited|||||12249341||||100|Ordinary|f1|||||
||||||||||||||||F2|
|The wholly<br>owned subsidiaries;|||MPS||Commercial||Limited|and Rare||Disease|Research||Partners||Limited|
|and trading<br>and dormant||respectively.|||Both subsidiaries|||are incorporated|||in England||and Wales, and|||
|have<br>the<br>registered|office||of|MPS||House,|Repton||Place,|White|Lion|Road,||Amersham,||
|Buckinghamshire,<br>HP7|9LP. All|||profits||generated|by subsidiaries|||are distributed||via Gift||Aid|to the|
|parent charity under a Deed of Covenant.||||||||||||||||
|||||||MPS Commercial<br>Limited|||||Rare||Disease Research<br>Partners<br>Limited|||
||||||||2021<br>f|||2020<br>f|||2021<br>f||2020<br>f|
|Fixed assets|||||||1,272|||572||||||
|Current assets||||||942,831|||1,318,376||||1||1|
|Current<br>habilities||||||(944,102)|||(1,318,947)|||||||
|Aggregate<br>share capital and||reserves||||||||||||||
|Net income from trading<br>activities||||||133,218|||350042|||||||



## 

## 



## 

## 

## 

## 

|19.|DEBT|O|RS: AMOUNTS|FALLING DUE WITHIN ONE YEAR|FALLING DUE WITHIN ONE YEAR|FALLING DUE WITHIN ONE YEAR||||
|---|---|---|---|---|---|---|---|---|---|
|||||||2021|2021|2020|2020|
|||||||Group|Charity|Group|Charity|
||||||||6|6|6|
|Trade|debtors|||||260,428|120|249,503|20|
|Amounts<br>owed by group undertakings|||||||333,217||601,667|
|Other|debtors|||||10,257|6,930|51,387|2,259|
|Prepayments|||and accrued income|||44,412|14,412|6,269|6,269|
|||||||315,097|354,679|307,159|610,215|
|20.|CASH|AT BANK AND IN|||HAND|||||
|||||||2021|2021|2020|2020|
|||||||Group|Charity|Group|Charity|
|||||||6|6|6||
|Cash|held|in|parent charity|||1,160,156|1,160,157|1,007,555|1,007,555|
|Cash|held|in|subsidiary|||541,271|-|1,019,765||
|||||||1,701,427|1,160,157|2,027,320|1,007,555|
|21.|CREDITORS: AMOUNTS||||FALLING DUE WITHIN ONE YEAR|||||
|||||||2021|2021|2020|2020|
|||||||Group|Charity|Group|Charity|
|||||||F|F|6|6|
|Trade creditors||||||19,087|6,013|16,282|5,337|
|Other creditors||||||546,205|58,321|753,259|48,755|
|Accrued expenses||||||9,305|7,305|8,430|6,600|
|||||||574,597|71,639|777,971|60,692|



## 

||2021|2021|2021|2020|2020|2020|
|---|---|---|---|---|---|---|
||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
||funds|funds|Funds|funds|Funds|Funds|
||6||Z|F|f|6|
|Fixed assets|1,061,737||1,061,737|1,089,613||1,089,612|
|Investments|315,348||315,348|310,897||310,897|
|Current assets|1,841,122|175,402|2,016,524|2,016,428|318,050|2,334,479|
|Current<br>liabilities|(574,597)||(574,597)|(777,971)||(777,971)|
||2,643,610|175,402|2,819,012|2,638,967|318,050|2,957,017|





## 

## 

## 

## 

|Group||||||||
|---|---|---|---|---|---|---|---|
||||Funds at||||Funds at 31|
||||1 January|||Fund|December|
||||2021|Income|Expenditure|Transfers|2021|
|Unrestricted<br>funds||||||||
|General charitable||fund|750,000|1,160,891|(1,127,539)|(33,352)|750,000|
|Property<br>fund|||1,084,520||(28,709)||1,055,811|
|Designated<br>funds||||||||
|Research fund|||367,297||||367,297|
|Service development<br>fund|||237,150|||33,352|270,502|
|Building<br>refurbishment<br>fund|||100,000||||100,000|
|Christine<br>Lavery<br>memorial<br>fund|||100,000||||100,000|
||||804,447|||33,352|837,799|
|Total unrestricted|funds||2,638,967|1,160,891|1,156,248||2,643,610|
|Restricted funds||||||||
|MPS restricted<br>fund|||192,757|282,355|(425,003)||50,109|
|LSD restricted<br>fund|||15,916||||15,916|
|Research restricted||fund|109,377||||109,377|
|Total restricted<br>funds|||318,050|282,355|~425,003||175,402|
|Total Funds|||2,957,017|1,443,246|~1,581,252||2,819,012|
|Charity||||||||
||||Funds at||||Funds at 31|
||||1January|||Fund|December|
||||2021|Income|Expenditure|Transfers|2021|
|Unrestricted<br>funds||||||||
|General charitable||fund|750,000|446,990|(413,638)|(33,352)|750,000|
|Property<br>fund|||1,084,520||(28,709)||1,055,811|
|Designated<br>funds||||||||
|Research fund|||367,297||||367,267|
|Service development<br>fund|||237,150|||33,352|270,502|
|Building<br>refurbishment<br>fund|||100,000||||100,000|
|Christine<br>Lavery<br>memcnal<br>fund|||100,000||||100,000|
||||804,446||||837,799|
|Total unrestricted|funds||2,638,967|1,160,881|~1,156,248||2,643,610|
|Restricted funds||||||||
|MPS restricted<br>fund|||192,757|282,355|(425,003)||50,109|
|LSD restricted<br>fund|||15,916||||15,916|
|Research restricted||fund|109,377||||109,377|
|Total restricted<br>funds|||318,050|282,355|~425,003||175,402|
|Total Funds|||2,957,017|1,443,246|~1,582,2523||2,819,012|





## 

## 

|Group|||||||
|---|---|---|---|---|---|---|
|||Funds at||||Funds at 31|
|||1 January|||Fund|December|
|||2020|Income|Expenditure|Transfers|2020|
|Unrestricted<br>funds|||||||
|General<br>charitable||752,815|1,310,192|(959,614)|(353,393)|750,000|
|Property<br>fund||1,113,228||(28,708)||1,084,520|
|Research fund||250,000||(9,400)|126,697|367,297|
|Service development||150,000||(39,546)|126,696|237,150|
|Building<br>refurbishment||100,000||||100,000|
|Christine<br>Lavery|||||100000|100,000|
|||500,000||(48,946)|353,392|804,447|
|Total unrestricted||2,366,043|1,310,192|~7,037,268||2,638,967|
|Restri cted funds|||||||
|MPS restricted||31,921|635,877|(475,041)||192,757|
|LSD restricted||16,749||(833)||15,916|
|Research<br>restricted|||109,377|||109,377|
|7 11<br>\1<br>I 01|0|48670|745,254|475,874||318050|
|TotalFunds||2,414,713|2,055,446|~7,523,742||2,957,017|
|Charity|||||||
|||Funds at||||Funds at 31|
|||1 January|||Fund|December|
|||2020|Income|Expenditure|Transfers|2020|
|Unrestricted<br>funds|||||||
|General<br>charitable||752,815|661,699|(311,121)|(353,393)|750,000|
|Property<br>fund||1,113,228||(28,708)||1,084,520|
|Research fund||250,000||(9,400)|126,697|367,297|
|Service development||150,000||(39,546)|126,696|237,150|
|Building<br>refurbishment||100,000||||100,000|
|Christine<br>Lavery|||||100,000|100,000|
|||500,000||(48,946)||804,446|
|Total unrestricted||2,366,043|661,699|~388,775||2,638,967|
|Restricted funds|||||||
|MPS restricted||31,921|635,877|(475,041)||192,757|
|LSD restricted||16,749||(833)||15,916|
|Research restricted|||109,377|||109,377|
|Total restricted||48,670|745,254|~475,874||318,050|
|Total Funds||2,414,713|1,4tt6,953|~7864,649||2,957,017|





## 

## 

## 

## 

## 

##